MLK-ENDO-205

ENDO-205 is an experimental, first-of-its-kind peptide medicine designed to treat endometriosis. It is being developed by a company called EndoCyclic Therapeutics.

Unlike normal treatments that use strong hormones to stop your period or cause temporary menopause, ENDO-205 does not touch your hormones at all.

In Plain Words: What Is It?

Think of endometriosis as misplaced tissue growing outside the uterus, causing painful bumps or scars called "lesions". Current drugs just try to hide the pain by shutting down your body's natural hormones. ENDO-205 acts like a smart, targeted missile. It ignores the healthy parts of your body, finds those painful lesions, and destroys them directly.

Key Benefits

Scientists are excited about ENDO-205 because it offers major changes to women's healthcare:

• No Hormonal Side Effects: Because it is non-hormonal, it avoids awful side effects like hot flashes, mood swings, or bone loss caused by older drugs.

• Protects Fertility: It does not stop you from ovulating, meaning women could theoretically stay fertile during treatment.

• Aims for a True Cure: Instead of just masking daily pain, a short 3-month course aims to clear out and eliminate the tissue lesions entirely so they do not come back.

Is it Systemic and How Does It Work?

Yes, ENDO-205 works systemically but targets locally.

1. How it enters: It travels through the body to locate the disease, but it uses a high-tech pH-sensitive design.

2. How it targets: Endometriosis lesions have a slightly different, more acidic environment than healthy tissues. ENDO-205 behaves like a key that only unlocks when it senses that specific tissue acidity.

3. What it does inside: Once it activates inside the diseased cells, it blocks a specific chemical pathway (called the Wnt/β-catenin pathway). This instantly stops the cells from multiplying, moving, or forming painful scars.

What is its Half-Life?

Because human testing just recently began, the exact biological half-life in humans is not yet public.

However, we do know how it survives in the body:

• Cell-Permeating Shield: Normal peptides get eaten up by blood enzymes right away. ENDO-205 is engineered as a "cell-permeating" peptide.

• Fast and Targeted Uptake: It is built to quickly sneak inside the diseased cells rather than floating around in the bloodstream for weeks. Once inside the lesion cells, it does its job locally to destroy them.

Current Status

In March 2026, the FDA cleared ENDO-205 to begin Phase 1 human clinical trials. This means scientists are currently testing it on small groups of real women for the very first time to make sure it is completely safe. It is a massive scientific leap, but it is not available for doctors to prescribe just yet.

• 
  

  ⚠️Important Notice:

  This product is intend for in-vitro laboratory research use only. It is not for human or veterinary use. Molekula USA does not condone the ingestion or injection of this compound. All customers must be qualified researchers.